Harmonet

Harmonet is a combined oral contraceptive tablet containing the synthetic estrogen ethinylestradiol and the progestogen gestodene. It is supplied in tablet form and marketed in the European Union as a prescription‑only medication. The product works by suppressing ovulation and altering cervical mucus and the endometrial lining to prevent pregnancy. Harmonet is classified under ATC code G03AA07. It is intended for women seeking birth control and to help regulate menstrual cycles.

Harmonet is prescribed primarily for hormonal contraception and menstrual cycle management.

- Prevention of pregnancy in women of reproductive age. - Regulation of irregular menstrual bleeding. - Reduction of dysmenorrhea associated with ovulatory cycles. - Management of acne that improves with estrogen‑progestogen therapy. - May be used as part of a post‑abortion or postpartum contraceptive plan under medical supervision.

Like other combined oral contraceptives, Harmonet can cause a range of side effects that vary in frequency and severity.

Common: - Nausea or mild stomach upset. - Breast tenderness or enlargement. - Headache or mild migraine. - Spotting or breakthrough bleeding between periods. - Weight fluctuation or fluid retention. - Mood changes such as irritability.

Serious: - Deep vein thrombosis or pulmonary embolism. - Stroke or transient ischemic attack. - Severe hypertension. - Liver dysfunction or jaundice. - Allergic reactions with rash or swelling.

Before starting Harmonet, healthcare providers assess several health factors to ensure safe use.

- History of thromboembolic disorders, stroke, or myocardial infarction. - Uncontrolled hypertension or diabetes with vascular complications. - Current or past smoking in women over 35 years of age. - Known liver disease or severe gallbladder disease. - Pregnancy or suspected pregnancy (category X). - Breast cancer or estrogen‑dependent tumors. - Migraine with aura.

Harmonet may interact with other medicines, affecting its effectiveness or increasing health risks.

Avoid: - Strong enzyme inducers such as rifampicin, carbamazepine, phenytoin, and St John’s wort. - Anticoagulants like warfarin, which may have reduced efficacy. - Certain antiviral agents (e.g., protease inhibitors) that alter hormone metabolism.

Use with caution: - Antidepressants (SSRIs) that can increase bleeding risk. - Antifungal agents (ketoconazole, itraconazole) that may raise hormone levels. - Diuretics or antihypertensives that may affect blood pressure control.